Thomas Hallam
Plus aucun poste en cours
Fortune : 10 $ au 31/05/2024
Profil
Thomas M.
Hallam served as the Chief Executive Officer & Director at Leading Biosciences, Inc. from 2017 to 2022.
He also held the position of Chief Executive Officer & Director at Palisade Bio, Inc. in 2021.
Prior to these roles, he worked as the Director-Therapeutic Programs at Mesoblast, Inc. and Mesoblast Ltd.
from 2012 to 2014.
Additionally, he served as the Medical Director at Saatchi & Saatchi North America LLC.
Dr. Hallam holds an MBA from the University of Southern California, a doctorate from the University of California, Davis, and an undergraduate degree from the University of Illinois.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PALISADE BIO, INC.
0,00% | 16/05/2024 | 2 ( 0,00% ) | 10 $ | 31/05/2024 |
Anciens postes connus de Thomas Hallam
| Sociétés | Poste | Fin |
|---|---|---|
Leading Biosciences, Inc.
 Leading Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Leading Biosciences, Inc. provides healthcare services. It offers therapy for severe sepsis, septic shock, and multi-organ failure. The company was founded by John Rodenrys and is headquartered in Carlsbad, CA. | Directeur Général | 11/10/2022 |
| PALISADE BIO, INC. | Directeur Général | 11/10/2022 |
| MESOBLAST LIMITED | Corporate Officer/Principal | 01/01/2014 |
Saatchi & Saatchi North America LLC
 Saatchi & Saatchi North America LLC Advertising/Marketing ServicesCommercial Services Saatchi & Saatchi North America, Inc. provides advertising services. It offers creative advertising services and plans marketing campaigns for advertisers and global companies. The company was founded in 1970 and is headquartered in New York, NY. | Directeur Technique/Scientifique/R&D | - |
Mesoblast, Inc.
 Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Mesoblast, Inc. manufactures and distributes biopharmaceutical products. It develops cellular medicines for under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Formation de Thomas Hallam
| University of California, Davis | Doctorate Degree |
| University of Southern California | Masters Business Admin |
| University of Illinois | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PALISADE BIO, INC. | Health Technology |
| MESOBLAST LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
Leading Biosciences, Inc.
Leading Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Leading Biosciences, Inc. provides healthcare services. It offers therapy for severe sepsis, septic shock, and multi-organ failure. The company was founded by John Rodenrys and is headquartered in Carlsbad, CA. | Commercial Services |
Mesoblast, Inc.
Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Mesoblast, Inc. manufactures and distributes biopharmaceutical products. It develops cellular medicines for under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. | Health Technology |
Saatchi & Saatchi North America LLC
Saatchi & Saatchi North America LLC Advertising/Marketing ServicesCommercial Services Saatchi & Saatchi North America, Inc. provides advertising services. It offers creative advertising services and plans marketing campaigns for advertisers and global companies. The company was founded in 1970 and is headquartered in New York, NY. | Commercial Services |
